Shares of AMRIZE N cratered 9.2% to CHF 37.98 on August 8 after the specialty-chemicals and services company posted a Q2 earnings miss and slashed its full-year profit outlook, signaling that oil-driven cost inflation is eating into margins faster than management anticipated just three months ago.
The Earnings Miss Wasn't Enormous, but the Guidance Cut Spooked Investors AMRIZE delivered Q2 adjusted earnings per share of $0.88, falling 7.4% short of the $0.95 Wall Street consensus. Revenue of $3.494 billion was respectable, yet the shortfall on the bottom line reveals the company couldn't pass rising input costs through to customers fast enough. More damaging: management lowered full-year adjusted EBITDA guidance to $3.1–$3.2 billion, down from the prior $3.25–$3.34 billion range. At the midpoint, that's roughly a $145 million haircut to expected cash profits — the kind of revision that forces analysts to rework their models and often triggers a round of price-target cuts.
Oil Is the Culprit, and It's Not Fully in AMRIZE's Control The company blamed higher crude-linked costs — freight, diesel, and petrochemical-derived raw materials — for the margin squeeze. Adjusted EBITDA margin fell to 28.2% from 29.0% a year earlier, an 80-basis-point decline that translates directly into less cash available for debt repayment, buybacks, or reinvestment. Because oil prices are set by global supply-and-demand dynamics, AMRIZE has limited near-term leverage to reverse the trend; its main levers are price increases and operational efficiency, both of which take quarters to show up in results.
The Stock's Recent Rally Made the Fall Steeper AMRIZE shares had climbed from $39.68 on July 31 to $42.55 by August 5 — a roughly 7% run-up — suggesting some investors had positioned for a beat. That pre-earnings optimism amplified today's sell-off: the stock gave back the entire rally and then some, wiping out more than $3.80 per share in a single session. Traders who bought on momentum were left holding the bag.
What to Watch Next The critical question is whether AMRIZE can restore margins by pushing through price hikes without losing volume. If oil stays elevated and the company can't offset costs by early Q3, the lower end of the new $3.1 billion EBITDA floor could come into play — a scenario that would likely trigger another leg down. For now, the market is telling AMRIZE that hope is not a cost strategy.